Medical Device, Biotech Cos. Price IPOs Raising $30M Total

Law360 (February 14, 2018, 4:19 PM EST) -- Israeli medical device company Motus GI Holdings Inc. and German biotechnology firm BioFrontera Inc. raised a combined $30 million from U.S. initial public offerings and saw shares begin trading Wednesday, representing the only two operating companies set to price in a quiet week for IPOs. 

Motus GI sold 3.5 million shares priced at $5 each, representing the bottom of its projected range of $5 to $7, raising $18 million in a downsized offering. The company, advised by Lowenstein Sandler LLP, previously planned to sell 4.25 million shares.

BioFrontera also sold 1.2 million American depositary shares at $9.88 each, raising $12 million....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS